State of New Jersey Common Pension Fund D grew its stake in TriMas Co. (NASDAQ:TRS – Free Report) by 8.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 102,562 shares of the industrial products company’s stock after purchasing an additional 7,903 shares during the period. State of New Jersey Common Pension Fund D owned approximately 0.25% of TriMas worth $2,598,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also made changes to their positions in TRS. Redmond Asset Management LLC grew its position in shares of TriMas by 157.8% in the third quarter. Redmond Asset Management LLC now owns 67,042 shares of the industrial products company’s stock valued at $1,660,000 after purchasing an additional 41,036 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in TriMas by 31.4% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,089 shares of the industrial products company’s stock worth $225,000 after acquiring an additional 2,173 shares during the period. Inspire Investing LLC purchased a new position in TriMas in the third quarter worth approximately $308,000. Versor Investments LP purchased a new position in TriMas in the third quarter worth approximately $414,000. Finally, Merit Financial Group LLC purchased a new position in TriMas in the third quarter worth approximately $909,000. 99.42% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at TriMas
In other news, CEO Thomas A. Amato purchased 10,000 shares of the stock in a transaction dated Friday, March 1st. The stock was acquired at an average cost of $23.62 per share, for a total transaction of $236,200.00. Following the completion of the transaction, the chief executive officer now directly owns 286,168 shares in the company, valued at approximately $6,759,288.16. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 1.30% of the company’s stock.
TriMas Trading Down 2.8 %
TriMas (NASDAQ:TRS – Get Free Report) last issued its quarterly earnings data on Thursday, February 29th. The industrial products company reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.54 by ($0.17). The business had revenue of $209.60 million during the quarter, compared to analysts’ expectations of $246.44 million. TriMas had a return on equity of 8.85% and a net margin of 4.52%. The company’s revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.62 earnings per share. As a group, research analysts predict that TriMas Co. will post 1.91 earnings per share for the current year.
TriMas Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, May 14th. Stockholders of record on Tuesday, May 7th will be given a dividend of $0.04 per share. The ex-dividend date of this dividend is Monday, May 6th. This represents a $0.16 annualized dividend and a dividend yield of 0.62%. TriMas’s dividend payout ratio is currently 16.49%.
TriMas Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Recommended Stories
- Five stocks we like better than TriMas
- How to Find Undervalued Stocks
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- The 3 Best Retail Stocks to Shop for in August
- Hilton Demonstrates Asset Light is Right for Investors
- 10 Best Airline Stocks to Buy
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.